HIGH SENSITIVITY C-REACTIVE PROTEIN
Clinical trials for HIGH SENSITIVITY C-REACTIVE PROTEIN explained in plain language.
Never miss a new study
Get alerted when new HIGH SENSITIVITY C-REACTIVE PROTEIN trials appear
Sign up with your email to follow new studies for HIGH SENSITIVITY C-REACTIVE PROTEIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to calm inflammation in kidney disease patients
Disease control CompletedThis study tested a drug called TOUR006 in 143 adults with chronic kidney disease and high levels of a protein linked to inflammation (hs-CRP). The goal was to see if monthly or quarterly shots could safely lower inflammation. The study is complete, and results will show if the d…
Matched conditions: HIGH SENSITIVITY C-REACTIVE PROTEIN
Phase: PHASE2 • Sponsor: Tourmaline Bio, Inc., a Novartis Company • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Turmeric and black pepper combo shows promise for heart attack patients
Disease control CompletedThis study looked at whether taking a supplement containing curcumin (from turmeric) and piperine (from black pepper) could help reduce inflammation and oxidative stress in 50 adults who had a severe heart attack and underwent a procedure to open blocked arteries. Participants to…
Matched conditions: HIGH SENSITIVITY C-REACTIVE PROTEIN
Phase: NA • Sponsor: Universitas Diponegoro • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC